Literature DB >> 22001593

Characteristics of multidrug-resistant Mycobacterium tuberculosis in southern Brazil.

Paulo F Perizzolo1, Elis R Dalla Costa, Andrezza W Ribeiro, Fernanda S Spies, Marta O Ribeiro, Cláudia F Dias, Gisela Unis, Pedro Almeida da Silva, Harrison M Gomes, Philip N Suffys, Maria Lucia R Rossetti.   

Abstract

A major threat to tuberculosis (TB) control programs is the emergence of drug resistant Mycobacterium tuberculosis strains that cause TB that cannot be cured by standard anti-TB drug regimens. Because few data exist on MDR-TB in this region of the country, we performed an epidemiologic study that combined conventional and molecular analysis of MDR-TB cases from Rio Grande do Sul (RS) that were diagnosed in this period and included cases that were under treatment with second line drug schemes. Included were 121 MDR cases and sequencing of rpoB and katG showed that 106 (87.6%) strains were mutated in rpoB and 97 (80.2%) in katG. Spoligotyping demonstrated that the LAM genotype was predominant (n = 70, 57.8%) and included the largest group composed by 22 (18.1%) strains with the LAM5 ST93 genotype. Other main genotypes belonged to the families T (n = 22, 18.2%), U family (n = 16, 13.2%), Haarlem (n = 5, 4.1%) and X (n = 1, 0.8%). Genotyping by IS6110-RFLP analysis showed 51 distinct fingerprints, 38 (31.4%) of these observed only once and the other 13 patterns being shared among the rest of the isolates (n = 83, 68.6%). Among the 22 strains that were LAM5 ST93, only two had different IS6110-RFLP genotypes. In conclusion, there exists a high degree of M. Tuberculosis genotype clustering among MDR-TB cases in Rio Grande do Sul. Moreover, we observed a large MDR-TB outbreak.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001593     DOI: 10.1016/j.tube.2011.09.008

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  19 in total

1.  Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis.

Authors:  V R Bollela; E I Namburete; C S Feliciano; D Macheque; L H Harrison; J A Caminero
Journal:  Int J Tuberc Lung Dis       Date:  2016-08       Impact factor: 2.373

2.  Predominant Mycobacterium tuberculosis Families and High Rates of Recent Transmission among New Cases Are Not Associated with Primary Multidrug Resistance in Lima, Peru.

Authors:  Francesca Barletta; Larissa Otero; Bouke C de Jong; Tomotada Iwamoto; Kentaro Arikawa; Patrick Van der Stuyft; Stefan Niemann; Matthias Merker; Cécile Uwizeye; Carlos Seas; Leen Rigouts
Journal:  J Clin Microbiol       Date:  2015-03-25       Impact factor: 5.948

3.  Mycobacterium tuberculosis of the RDRio genotype is the predominant cause of tuberculosis and associated with multidrug resistance in Porto Alegre City, South Brazil.

Authors:  Elis Regina Dalla Costa; Luiz Claudio Oliveira Lazzarini; Paulo Fernado Perizzolo; Chyntia Acosta Díaz; Fernanda S Spies; Lucas Laux Costa; Andrezza W Ribeiro; Caroline Barroco; Sandra Jungblut Schuh; Marcia Aparecida da Silva Pereira; Claudia F Dias; Harrison M Gomes; Gisela Unis; Arnaldo Zaha; Pedro E Almeida da Silva; Philip N Suffys; Maria L R Rossetti
Journal:  J Clin Microbiol       Date:  2013-01-16       Impact factor: 5.948

4.  Multidrug-Resistant Mycobacterium tuberculosis of the Latin American Mediterranean Lineage, Wrongly Identified as Mycobacterium pinnipedii (Spoligotype International Type 863 [SIT863]), Causing Active Tuberculosis in South Brazil.

Authors:  Elis R Dalla Costa; Sidra E G Vasconcelos; Leonardo S Esteves; Harrison M Gomes; Lia L Gomes; Pedro Almeida da Silva; João Perdigão; Isabel Portugal; Miguel Viveiros; Ruth McNerney; Arnab Pain; Taane G Clark; Nalin Rastogi; Gisela Unis; Maria Lucia R Rossetti; Philip Noel Suffys
Journal:  J Clin Microbiol       Date:  2015-12       Impact factor: 5.948

5.  Molecular profiling of drug resistant isolates of Mycobacterium tuberculosis in the state of Santa Catarina, southern Brazil.

Authors:  Rodrigo Ivan Prim; Marcos André Schörner; Simone Gonçalves Senna; Christiane Lourenço Nogueira; Anna Carolina Cançado Figueiredo; Jaquelline Germano de Oliveira; Darcita Bürger Rovaris; Maria Luiza Bazzo
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-07-07       Impact factor: 2.743

6.  Tuberculosis recurrence in a high incidence setting for HIV and tuberculosis in Brazil.

Authors:  Gisela Unis; Andrezza Wolowski Ribeiro; Leonardo Souza Esteves; Fernanda Sá Spies; Pedro Dornelles Picon; Elis Regina Dalla Costa; Maria Lucia Rosa Rossetti
Journal:  BMC Infect Dis       Date:  2014-10-24       Impact factor: 3.090

7.  Genetic diversity and molecular epidemiology of multidrug-resistant Mycobacterium tuberculosis in Minas Gerais State, Brazil.

Authors:  Nayanne Gama Teixeira Dantas; Phillip Noel Suffys; Wânia da Silva Carvalho; Harrison Magdinier Gomes; Isabela Neves de Almeida; Lida Jouca de Assis; Claudio José Augusto; Michel Kireopori Gomgnimbou; Guislaine Refregier; Christophe Sola; Silvana Spíndola de Miranda
Journal:  BMC Infect Dis       Date:  2015-08-01       Impact factor: 3.090

8.  Genetic variability of Mycobacterium tuberculosis complex in patients with no known risk factors for MDR-TB in the North-Eastern part of Lima, Peru.

Authors:  Francesca Barletta; Larissa Otero; Jimena Collantes; Belisa Asto; Bouke C de Jong; Carlos Seas; Leen Rigouts
Journal:  BMC Infect Dis       Date:  2013-08-28       Impact factor: 3.090

9.  Suitability of IS6110-RFLP and MIRU-VNTR for differentiating spoligotyped drug-resistant mycobacterium tuberculosis clinical isolates from Sichuan in China.

Authors:  Chao Zheng; Yuding Zhao; Guoqiang Zhu; Song Li; Honghu Sun; Qin Feng; Mei Luo; Fanzi Wu; Xuefeng Li; Véronique Hill; Nalin Rastogi; Qun Sun
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

10.  Multidrug resistant Mycobacterium tuberculosis: a retrospective katG and rpoB mutation profile analysis in isolates from a reference center in Brazil.

Authors:  Flávia A D de Freitas; Vagner Bernardo; Michel K Gomgnimbou; Christophe Sola; Hélio R Siqueira; Márcia A S Pereira; Fátima C O Fandinho; Harrison M Gomes; Marcelo E I Araújo; Philip N Suffys; Elizabeth A Marques; Rodolpho M Albano
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.